Del Carmen Jeffrey — SEC Form 4 filings

SEC reporting owner CIK 1816477. 13 Form 4 filings on record with FilingPulse; latest filed 2026-07-17.

Transaction summary — filings shown

Covers all 13 filings on record, filed 2024-02-16 to 2026-07-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CATALYST PHARMACEUTICALS, INC. (CPRX)Chief Commercial Officer135 legs · 85,005 sh · $1,738,12040

Form 4 filings — Del Carmen Jeffrey

FiledFormIssuerReported transactionsSource
2026-07-174CATALYST PHARMACEUTICALS, INC. (CPRX)Disposition to issuer (D): 14,337 @ $31.50 · Disposition to issuer (D): 150,000 (derivative) @ $0 · Disposition to issuer (D): 200,000 (derivative) @ $0 · Disposition to issuer (D): 135,000 (derivative) @ $0 · Disposition to issuer (D): 88,000 (derivative) @ $0 · Disposition to issuer (D): 167,918 (derivative) @ $0 · +5 moreEDGAR
2025-12-304CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 8,667 · Tax withholding (F): 3,839 · Option exercise (M): 8,667 (derivative) @ $0EDGAR
2025-12-104CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 8,039 · Tax withholding (F): 2,492 · Option exercise (M): 8,039 (derivative) @ $0EDGAR
2025-11-284CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 10,983 @ $4.21 · Sale (S): 10,983 @ $23.33 · Option exercise (M): 10,983 (derivative) @ $0EDGAR
2025-11-244CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 5,603 · Tax withholding (F): 1,641 · Grant/award (A): 106,873 (derivative) @ $0 · Grant/award (A): 32,257 (derivative) @ $0 · Option exercise (M): 5,603 (derivative) @ $0EDGAR
2025-03-054CATALYST PHARMACEUTICALS, INC. (CPRX)Sale (S): 30,423 @ $22.89EDGAR
2025-02-194CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 10,667 · Tax withholding (F): 3,125 · Option exercise (M): 10,667 (derivative) @ $0EDGAR
2024-12-314CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 8,667 · Tax withholding (F): 3,839 · Option exercise (M): 8,667 (derivative) @ $0EDGAR
2024-12-114CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 8,039 · Tax withholding (F): 2,355 · Option exercise (M): 8,039 (derivative) @ $0EDGAR
2024-11-254CATALYST PHARMACEUTICALS, INC. (CPRX)Grant/award (A): 137,553 (derivative) @ $0 · Grant/award (A): 16,809 (derivative) @ $0EDGAR
2024-08-134CATALYST PHARMACEUTICALS, INC. (CPRX)Sale (S): 6,058 @ $18.44 · Option exercise (M): 30,000 @ $2.86 · Sale (S): 30,000 @ $18.42 · Option exercise (M): 30,000 (derivative) @ $0EDGAR
2024-06-114CATALYST PHARMACEUTICALS, INC. (CPRX)Sale (S): 7,541 @ $16.07EDGAR
2024-02-164CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 10,667 · Tax withholding (F): 3,125 · Option exercise (M): 10,667 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1816477 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →